Skip to main content

Table 2 Correlation between miR-17-5p expression and clinicopathologic features of TNBC patients

From: miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer

Characteristics n miR-17-5p P value
High Low
Age (y)
  ≤ 50 63 14 (22%) 49 (78%) 1.000
  > 50 42 9 (21%) 33 (79%)
Tumour Size
  ≤ 2 cm 19 8 (42%) 11 (58%) 0.030*
  > 2 cm 86 15 (17%) 71 (83%)
Pathological type
 Invasive ductal carcinomas 93 19 (20%) 74 (80%) 0.292
 Others 12 4 (33%) 8 (67%)
TNM Stage
 I 6 3 (50%) 3 (50%) 0.022*
 II 34 11 (32%) 23 (68%)
 III 65 9 (14%) 56 (86%)
Lymph node metastasis
 0–4 45 15 (33%) 30 (67%) 0.050
 5–8 39 6 (15%) 33 (85%)
  ≥ 9 21 2 (10%) 19 (90%)
Relapse
 No 67 18 (27%) 49 (73%) 0.141
 Yes 38 5 (13%) 33 (87%)
  1. *means P < 0.05; Fisher exact test